ATE426169T1 - Fruher nachweis einer lysosomalen speicher- krankheit - Google Patents
Fruher nachweis einer lysosomalen speicher- krankheitInfo
- Publication number
- ATE426169T1 ATE426169T1 AT97920460T AT97920460T ATE426169T1 AT E426169 T1 ATE426169 T1 AT E426169T1 AT 97920460 T AT97920460 T AT 97920460T AT 97920460 T AT97920460 T AT 97920460T AT E426169 T1 ATE426169 T1 AT E426169T1
- Authority
- AT
- Austria
- Prior art keywords
- lysosomal storage
- early detection
- storage disease
- detection
- lamp
- Prior art date
Links
- 208000015439 Lysosomal storage disease Diseases 0.000 title abstract 3
- 238000001514 detection method Methods 0.000 title abstract 3
- GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 abstract 2
- 102000013563 Acid Phosphatase Human genes 0.000 abstract 2
- 108010051457 Acid Phosphatase Proteins 0.000 abstract 2
- 101150117895 LAMP2 gene Proteins 0.000 abstract 1
- 101150048357 Lamp1 gene Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 102000019199 alpha-Mannosidase Human genes 0.000 abstract 1
- 108010012864 alpha-Mannosidase Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPN9917A AUPN991796A0 (en) | 1996-05-17 | 1996-05-17 | Early detection of lysosomal storage disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE426169T1 true ATE426169T1 (de) | 2009-04-15 |
Family
ID=3794228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97920460T ATE426169T1 (de) | 1996-05-17 | 1997-05-16 | Fruher nachweis einer lysosomalen speicher- krankheit |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US6759189B1 (https=) |
| EP (1) | EP1021725B1 (https=) |
| JP (3) | JP3837711B2 (https=) |
| AT (1) | ATE426169T1 (https=) |
| AU (1) | AUPN991796A0 (https=) |
| CA (2) | CA2731490A1 (https=) |
| DE (1) | DE69739317D1 (https=) |
| IL (1) | IL127033A (https=) |
| NZ (1) | NZ332641A (https=) |
| WO (1) | WO1997044668A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1181550A4 (en) * | 1999-04-30 | 2005-03-02 | Nathan S Kline Inst For Psychi | METHODS OF IDENTIFYING COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
| US7090987B1 (en) | 1999-04-30 | 2006-08-15 | Nixon Ralph A | Methods for the identification of compounds for the treatment of neuronal atrophy-associated dementia |
| ATE550664T1 (de) | 2003-03-31 | 2012-04-15 | Womens & Childrens Hospital | Multiplex-screening auf lysosomale speicherkrankheiten (lsds) |
| US7615224B2 (en) | 2004-12-02 | 2009-11-10 | Women's And Children's Hospital | Multiplex-bead complex for determination of lysosomal storage disorders |
| ES2301280A1 (es) * | 2005-05-16 | 2008-06-16 | Fina Biotech S.L.U. | Metodo para diagnosticar la enfermedad de alzheimer. |
| WO2007136782A2 (en) * | 2006-05-19 | 2007-11-29 | Historx, Inc. | Kits and methods for evaluating misfolded proteins |
| WO2008070892A1 (en) * | 2006-12-13 | 2008-06-19 | Tgr Biosciences Pty Ltd | Promoting production of extracellular matrix by fibroblast cells and/or promoting migration of fibroblast cells |
| AU2009223092A1 (en) * | 2008-03-12 | 2009-09-17 | Amicus Therapeutics, Inc | Treatment of Pompe disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| US8497122B2 (en) * | 2008-04-11 | 2013-07-30 | Washington University | Biomarkers for Niemann-pick C disease and related disorders |
| GB201114909D0 (en) * | 2011-08-30 | 2011-10-12 | San Raffaele Centro Fond | Biomarkers for lysosomal storage disorders |
| US8293487B1 (en) * | 2012-01-06 | 2012-10-23 | Jiandi Zhang | Zestern, a simple, fast, specific and quantifiable improvement of immunodetection process |
| WO2014153083A1 (en) | 2013-03-14 | 2014-09-25 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect |
| US12020820B1 (en) | 2017-03-03 | 2024-06-25 | Cerner Innovation, Inc. | Predicting sphingolipidoses (fabry's disease) and decision support |
| US11335461B1 (en) | 2017-03-06 | 2022-05-17 | Cerner Innovation, Inc. | Predicting glycogen storage diseases (Pompe disease) and decision support |
| US11923048B1 (en) | 2017-10-03 | 2024-03-05 | Cerner Innovation, Inc. | Determining mucopolysaccharidoses and decision support tool |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4859581A (en) * | 1986-03-10 | 1989-08-22 | Board Of Regents, The University Of Texas System | Endoglycosidase assay |
| AU2990692A (en) | 1991-12-06 | 1993-06-10 | Commonwealth Scientific And Industrial Research Organisation | Diagnostic method for pompe's disease |
| WO1994010340A1 (en) * | 1992-10-30 | 1994-05-11 | Mt. Sinai Hospital Corporation | Method for measuring glycosyltransferase activity |
-
1996
- 1996-05-17 AU AUPN9917A patent/AUPN991796A0/en not_active Abandoned
-
1997
- 1997-05-16 JP JP54126497A patent/JP3837711B2/ja not_active Expired - Fee Related
- 1997-05-16 WO PCT/AU1997/000304 patent/WO1997044668A1/en not_active Ceased
- 1997-05-16 US US09/180,657 patent/US6759189B1/en not_active Expired - Fee Related
- 1997-05-16 NZ NZ332641A patent/NZ332641A/xx not_active IP Right Cessation
- 1997-05-16 CA CA2731490A patent/CA2731490A1/en not_active Abandoned
- 1997-05-16 CA CA2253875A patent/CA2253875C/en not_active Expired - Fee Related
- 1997-05-16 IL IL12703397A patent/IL127033A/xx not_active IP Right Cessation
- 1997-05-16 DE DE69739317T patent/DE69739317D1/de not_active Expired - Lifetime
- 1997-05-16 AT AT97920460T patent/ATE426169T1/de not_active IP Right Cessation
- 1997-05-16 EP EP97920460A patent/EP1021725B1/en not_active Expired - Lifetime
-
2004
- 2004-01-13 US US10/756,011 patent/US20040191847A1/en not_active Abandoned
-
2005
- 2005-09-28 JP JP2005283143A patent/JP4260152B2/ja not_active Expired - Fee Related
-
2008
- 2008-08-19 JP JP2008211239A patent/JP2008289501A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| NZ332641A (en) | 2000-05-26 |
| US20040191847A1 (en) | 2004-09-30 |
| DE69739317D1 (de) | 2009-04-30 |
| JP3837711B2 (ja) | 2006-10-25 |
| EP1021725B1 (en) | 2009-03-18 |
| CA2731490A1 (en) | 1997-11-27 |
| IL127033A0 (en) | 1999-09-22 |
| AUPN991796A0 (en) | 1996-06-13 |
| JP4260152B2 (ja) | 2009-04-30 |
| WO1997044668A1 (en) | 1997-11-27 |
| JP2008289501A (ja) | 2008-12-04 |
| CA2253875A1 (en) | 1997-11-27 |
| JP2006061161A (ja) | 2006-03-09 |
| EP1021725A1 (en) | 2000-07-26 |
| IL127033A (en) | 2000-12-06 |
| JP2001519894A (ja) | 2001-10-23 |
| US6759189B1 (en) | 2004-07-06 |
| CA2253875C (en) | 2011-02-22 |
| EP1021725A4 (en) | 2002-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE426169T1 (de) | Fruher nachweis einer lysosomalen speicher- krankheit | |
| PT98710A (pt) | Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem | |
| ES2172750T3 (es) | Microcapsulas sensibles al ph. | |
| BR9914044A (pt) | ésteres tetrahidropirido | |
| HN1998000113A (es) | Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion. | |
| DK0971600T3 (da) | Medicinsk levnedsmiddel til diabetikere | |
| ATE146360T1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
| BR9713866A (pt) | Composição farmacéutica | |
| WO2003104410A3 (en) | ENZYMES | |
| ES2158054T3 (es) | Extracto proteinico de cucumis melo con actividad antioxidante y procedimiento de preparacion, composicion cosmetica o farmaceutica o composicion alimenticia que contienen dicho extracto. | |
| BR0200571A (pt) | Produtos de legumes | |
| BR9808140A (pt) | Formulação unitária | |
| ITRM930291A0 (it) | Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti. | |
| CA2069611A1 (en) | Method to Detect Bone and Other Connective Tissue Disorders in Humans and Animals | |
| FR2809000B1 (fr) | Utilisation d'ergothioneine et/ou de ses derives comme agent anti-pollution | |
| ATE338142T1 (de) | Methoden zur diagnose und behandlung von herzkrankheiten | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| TR200000697T2 (tr) | İkame edilmiş 1,2,3,4,5,6-Heksahidro-2,6-Metano-3-Benzazosin-10-OL'ler, üretim yöntemleri ve farmasötik preparat olarak kullanımları. | |
| BR9814188A (pt) | "agonistas de 5-ht1f" | |
| DE69831737D1 (de) | Neurotrypsin | |
| DK0853476T5 (da) | Nimesulidholdigt farmaceutisk præparat til topisk anvendelse | |
| WO2002062205A3 (en) | Methods for diagnosing and treating heart disease | |
| BR0115689A (pt) | Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata | |
| TR199801398T2 (xx) | Ast�m� tedavi edici maddeler | |
| WO1999050671A3 (en) | Toso as a target for drug screening |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |